The Medicines and Healthcare products Regulatory Agency has warned that some Emerade auto-injector adrenaline pens may be defective, due to a blockage of the needle. Manufacturer Bausch & Lomb UK Ltd. detected the issue over a year ago but categorised it as a rare event due to the potential occurrence rate. However, further tests have indicated the number of occurrences could be nearly twice that of what was first anticipated.
Emerade 150 micrograms solution for injection in pre-filled syringe
Emerade 300 micrograms solution for injection in pre-filled syringe
Emerade 500 micrograms solution for injection in pre-filled syringe
The problem and the advice
It’s been calculated that there’s a 0.23% chance your Emerade will fail to deliver a dose when activated – that’s 2.3 in every 1,000 pens.
However, for those of you who are good at quick maths, providing you’re carrying two pens the chances of both failing are really, really small – just over 0.0005%.
This is why the official advice is to ensure, as always, that you carry two Emerade pens. This has been recommended anyway, in case you don’t improve after taking the first injection or the ambulance does not arrive promptly and you need a top-up.
Learn how to use an Emerade (and other auto-injectors)
Our anaphylaxis awareness course is aimed at anyone who may need to use an Emerade, Epipen or Jext auto-injector. It covers the recognition and treatment of anaphylaxis. Lean online here: www.protanaphylaxis.co.uk/training or phone 01206 805359 for more information or details of courses at your workplace.
Buy an Emerade training injection pen
Our Emerade Auto-Injector trainer pen is for use as part of training courses, or to refresh your skills and enable you to practise giving one. This is the latest unit, which is the only auto-injector to have a needle, as per the UK Resuscitation Council guidelines.